Clinical Trials Sponsored by American Society for Blood and Marrow Transplantation (ASBMT)

Total 38 results

European Society for Blood and Marrow Transplantation

Completed

A Case-control Study on Risk Factors, Timing, and PCR Use, for Pneumocystis Pneumonia (PcP) After Allogeneic HSCT

Pneumocystis Pneumonia

Belgium, Israel, France, Germany, Hungary, Norway
European Society for Blood and Marrow Transplantation

Enrolling by invitation

RACE 2: a Long Term Follow-up of Patients Participating in the RACE Trial (RACE2)

Severe Aplastic Anemia

France
European Society for Blood and Marrow Transplantation

Completed

Current Treatment of HCV Infection After HSCT

Hepatitis C

France, Spain, Italy
European Society for Blood and Marrow Transplantation

Not yet recruiting

Observational Study in Multiple Sclerosis Patients Treated With Autologous Hematopoietic Stem Cell Transplantation (OMST)

Multiple Sclerosis
European Society for Blood and Marrow Transplantation

Recruiting

EBMT ADWP Prospective Non-interventional Study: Post-AHSCT Management in SSC Patients (NISSC-2) (NISSC-2)

Autoimmune Diseases

France
European Society for Blood and Marrow Transplantation

Active, not recruiting

Central Nervous System Disorders Following Hematopoietic Stem Cell Transplantation

Central Nervous System Infections | Blood Disease | Infection | Blood Cancer | Central Nervous System Complication | Infectious Disease of Nervous System

Australia, Spain, Italy, Germany, France, Colombia, Hungary, Poland, Russian Federation, Tunisia, Turkey
European Society for Blood and Marrow Transplantation

Unknown

Impact of Pre-existing Invasive Aspergillosis on Allogeneic Stem Cell Transplantation (IPAT)

Invasive Aspergillosis

Germany, Turkey, Spain, Italy, Saudi Arabia, Switzerland
European Society for Blood and Marrow Transplantation

Completed

EBMT ADWP Prospective Non Interventional Study : AutoHSCT in SSc Patients (NISSC)

Autoimmune Diseases

France
European Society for Blood and Marrow Transplantation

Completed

Stem Cell Translpantation in Multiple Myeloma

Multiple Myeloma

Austria, Denmark, Germany, Finland, Canada, Sweden, Norway, France, Italy, United Kingdom, Turkey
European Society for Blood and Marrow Transplantation

Completed

Gram-negative Bacteremia in HSCT Recipients (GNB)

Allogeneic or Autologous HSCT

Sweden, China, Israel, Belgium, Germany, Croatia, Portugal, Russian Federation, Turkey
European Society for Blood and Marrow Transplantation

Completed

Allo SCT in Amyloidosis Non-interventional Study

AL Amyloidosis

Germany, France, Switzerland
European Society for Blood and Marrow Transplantation
Novartis

Completed

Non Interventional Study on Iron Toxicity After First Allo-transplant in MDS/CMML

MDS | CMML

Germany, Belgium, Czechia
European Society for Blood and Marrow Transplantation
Novartis

Terminated

Myfortic - Treatment for Extensive cGvHD

Graft vs Host Disease

Switzerland, Spain, Sweden, Italy, France, Germany, Netherlands, Turkey
European Society for Blood and Marrow Transplantation
Amgen

Withdrawn

Palifermin After Haploidentical PBSCT (KGF Haplo Allo)

Chronic Myeloid Leukemia | Myelodysplastic Syndrome | Acute Leukaemia | Non-Hodgkin's Lymphoma or Hodgkin's Disease | Osteomyelofibrosis

Germany
Pfizer
European Society for Blood and Marrow Transplantation

Completed

Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants (VOSIFI)

Prophylaxis Of Invasive Fungal Infections

Portugal, Belgium, France, Germany, Spain, United Kingdom, Switzerland, Sweden
European Society for Blood and Marrow Transplantation
Mallinckrodt

Completed

ECP Combination Study

Steroid Refractory GVHD

Spain, United Kingdom, Sweden, Italy, Israel, France, Denmark, Germany, Poland, Turkey, Romania, Belgium, Greece, Russian Federation
European Society for Blood and Marrow Transplantation
Novartis

Completed

Effect of 2nd Gen TKI in CML

Myeloid Leukemia, Chronic

Germany, Finland, Denmark, Poland, Saudi Arabia, United Kingdom, Israel, Hungary, Russian Federation
European Society for Blood and Marrow Transplantation
EULAR

Withdrawn

Autologous Stem Cell Transplantation: International Lupus Trial (ASTIL)

REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS

France
European Society for Blood and Marrow Transplantation
Novartis; Pfizer

Completed

hATG+CsA vs hATG+CsA+Eltrombopag for SAA (RACE)

Severe Aplastic Anemia

Switzerland, Netherlands, France, Italy, Spain, United Kingdom
Jazz Pharmaceuticals
European Society for Blood and Marrow Transplantation

Completed

European VOD Registry

Hepatic Veno-Occlusive Disease

France, United Kingdom, Italy, Portugal
European Society for Blood and Marrow Transplantation
The Broad Foundation

Terminated

ASTIC Autologous Stem Cell Transplantation for Crohn's Disease

Crohn Disease

United Kingdom, Italy, Switzerland, Belgium, Canada, France, Spain
European Society for Blood and Marrow Transplantation
Bristol-Myers Squibb

Terminated

Efficacy and Safety Study of Dasatinib in Patients With Chronic Myeloid Leukemia (Dasatinib)

Chronic Myeloid Leukemia

Switzerland, United Kingdom, France, Germany
University Hospital, Geneva
European Society for Blood and Marrow Transplantation

Recruiting

Polymorphisms and Busulfan Pharmacokinetic Study

Children Who Receive a Stem Cell Transplantation With Busulfan IV

Canada, France, Switzerland
European Society for Blood and Marrow Transplantation
CHUGAI sanofi-aventis

Terminated

Randomized Study In Severe Aplastic Anemia Patients Receiving Atg, Cyclosporin A, With Or Without G-CSF (SAA-G-CSF) (SAA-G-CSF)

Aplastic Anaemia

France, Netherlands, Germany, United Kingdom, Switzerland, Italy, Sweden, Greece, Czechia
European Society for Blood and Marrow Transplantation
Pierre Fabre Medicament

Terminated

Dose-reduced Versus Standard Conditioning in MDS/sAML (RICMAC)

Myelodysplastic Syndromes | Secondary Acute Myeloid Leukemia

Germany, Italy, Netherlands, Russian Federation
European Society for Blood and Marrow Transplantation
Genzyme, a Sanofi Company

Completed

Rabbit Antithymocyte Globulin (Thymoglobuline) With Ciclosporin for Patients With Acquired Aplastic Anaemia (RATGAA07)

Aplastic Anemia

Switzerland, United Kingdom, Germany, Italy, France, Saudi Arabia
European Society for Blood and Marrow Transplantation
Hoffmann-La Roche; Amgen

Completed

Peripheral Blood (PB) Versus Bone Marrow (BM) in Allogeneic Stem Cell Transplantation

Acute Leukemia | Myelodysplastic Syndrome | Chronic Myelogenous Leukemia

Germany
European Society for Blood and Marrow Transplantation
European Research Initiative on CLL

Completed

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in 17p- Chronic Lymphocytic Leukemia (CLL) (17p-CLL)

CLL

Germany, United Kingdom, Netherlands, Finland, Sweden, Denmark, Israel
Genzyme, a Sanofi Company
European Society for Blood and Marrow Transplantation

Completed

Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry on a Cohort of Patients Receiving Plerixafor

Lymphoma | Multiple Myeloma
Genzyme, a Sanofi Company
European Society for Blood and Marrow Transplantation

Completed

Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor

Lymphoma | Acute Leukemia | Myelodysplastic Syndrome | Solid Tumors | Myeloproliferative Neoplasm | Chronic Leukemia | Plasma Cell Disorders
European Society for Blood and Marrow Transplantation
Jazz Pharmaceuticals; Deutsche Krebshilfe e.V., Bonn (Germany)

Completed

Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide (VOD-DF)

Hepatic Veno-Occlusive Disease

Sweden, United Kingdom, Italy, Switzerland, Germany, Austria, France, Ireland, Israel, Netherlands
The First Affiliated Hospital of Soochow University
European Society for Blood and Marrow Transplantation

Unknown

Haplo-SCT vs ASCT With or Without Decitabine in AML CR1

Acute Myeloid Leukemia

China
Northwestern University
National Heart, Lung, and Blood Institute (NHLBI); American Society for Transplantation

Withdrawn

Mechanism of Hypertension Treatments in Liver Transplant Recipients (BLOCK LTR-HTN)

High Blood Pressure | Liver Transplant | Renal Function Abnormal

United States
European Society for Blood and Marrow Transplantation
Celgene Corporation; Johnson & Johnson Pharmaceutical Research & Development...

Terminated

MMVAR - Velcade: Study of Velcade for the Treatment of Myeloma Patients After Autologous Transplantation

Multiple Myeloma

France, Israel, Germany, Switzerland, Hungary, Czechia, United Kingdom, Austria, Belgium, Italy
Baylor College of Medicine
Cancer Prevention Research Institute of Texas; The Methodist Hospital Research... and other collaborators

Recruiting

Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM)

Acute Myeloid Leukemia | Myelodysplastic Syndrome

United States
Boston Children's Hospital
National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health... and other collaborators

Recruiting

A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202) (TransIT)

Severe Aplastic Anemia

United States
St. Anna Kinderkrebsforschung
Assistance Publique - Hôpitaux de Paris; Australian & New Zealand Children's... and other collaborators

Recruiting

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

Acute Lymphoblastic Leukaemia

Italy, Israel, Spain, Argentina, Australia, Austria, Belarus, Belgium, Canada, Chile, Croatia, Czechia, Denmark, Finland, Greece, Malaysia, Mexico, Netherlands, Norway, Poland, Romania, Saudi Arabia, Slovakia, Sweden, Switzerland, Turkey, F... and more
European Society for Blood and Marrow Transplantation
European Organisation for Research and Treatment of Cancer - EORTC; Swiss Group... and other collaborators

Terminated

HCT Versus CT in Elderly AML

Acute Myeloid Leukemia

Switzerland, Netherlands, Germany, France, Australia, Austria, Belgium

Clinical Trials Sponsored by American Society for Blood and Marrow Transplantation (ASBMT)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations